Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 5/20 | 0.58 |
| ▸ | CA1 | P00915 | 5/20 | 0.58 |
| ▸ | CA2 | P00918 | 5/20 | 0.58 |
| ▸ | CA9 | Q16790 | 5/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | TYMP | P19971 | 3/20 | 0.38 |
| ▸ | FPR2 | P25090 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6578379 | 0.88 | LMNA (0.67) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| SCHEMBL367133 | 0.87 | LMNA (0.68) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| SCHEMBL368130 | 0.86 | LMNA (0.78) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| Etanidazole SCHEMBL4414 | 0.84 | LMNA (1.00) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| Etanidazole SCHEMBL8171462 | 0.84 | LMNA (1.00) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| SCHEMBL13065132 | 0.84 | LMNA (0.74) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| Etanidazole SCHEMBL9473771 | 0.83 | LMNA (0.97) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| SCHEMBL8432165 | 0.83 | LMNA (0.78) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| SCHEMBL14499615 | 0.83 | LMNA (0.78) | LMNATHRBCYP2C19CYP3A4CYP2D6 | |
| SCHEMBL15610852 | 0.82 | LMNA (0.65) | LMNATHRBCYP2C19CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118351986-A | Textile product chemical footprint accounting method based on machine learning algorithm | 雅戈尔服装控股有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-7108846-B1 | Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection | UNIVERSITE CATHOLIQUE DE LOUVAN (BE) | 2006-09-19 | — | — | US | claimed |
| EP-1202945-B1 | METHODS FOR PREPARING PERFLUORINATED [18 F]-RADIOLABELLED NITROIMIDAZOLE DERIVATIVES FOR CELLULAR HYPOXIA DETECTION | UNIV CATHOLIQUE LOUVAIN (BE) | 2005-08-17 | — | — | EP | claimed |
| EP-1202945-A1 | METHODS FOR PREPARING PERFLUORINATED [18 F]-RADIOLABELLED NITROIMIDAZOLE DERIVATIVES FOR CELLULAR HYPOXIA DETECTION | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2002-05-08 | — | — | EP | claimed |
| WO-2001012575-A1 | METHODS FOR PREPARING PERFLUORINATED [18F]-RADIOLABELLED NITROIMIDAZOLE DERIVATIVES FOR CELLULAR HYPOXIA DETECTION | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2001-02-22 | — | — | WO | claimed |
| US-20260118497-A1 | Doppler Velocity Recovery and Dealiasing Algorithm for Multi-PRT Scans in Weather Radars | UNIV OKLAHOMA (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260062716-A1 | LIPID NANOPARTICLE (LNP) COMPOSITION OR FORMULATION FOR NUCLEIC ACID THERAPEUTICS | POPVAX PRIVATE LTD (IN) | 2026-03-05 | — | — | US | disclosed |
| US-20250388585-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12448388-B2 | PRMT5 inhibitors and uses thereof | GILEAD SCIENCES, INC. (US) | 2025-10-21 | — | — | US | disclosed |
| WO-2025217623-A1 | DOPPLER VELOCITY RECOVERY AND DEALIASING ALGORITHM FOR MULTI-PRT SCANS IN WEATHER RADARS | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2025-10-16 | — | — | WO | disclosed |
| US-12434104-B2 | Method for managing the use of an exercise machine by multiple users for performing physical exercises and exercise machine implementing such a method | TECHNOGYM S.P.A. (IT) | 2025-10-07 | — | — | US | disclosed |
| US-12348431-B1 | Automated scaling of packet processing service resources | AMAZON TECHNOLOGIES, INC. (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2008054824-A9 | METHODS FOR DIFFERENTIAL DETECTION OF HYPOXIC TISSUE IN A MAMMALIAN SUBJECT | TRUSTESS OF THE UNIVERSITY OF (US) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008054824-A2 | METHODS FOR DIFFERENTIAL DETECTION OF HYPOXIC TISSUE IN A MAMMALIAN SUBJECT | THE TRUSTESS OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2008-05-08 | — | — | WO | disclosed |
| US-7230115-B1 | Preparation of compounds useful for the detection of hypoxia | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2007-06-12 | — | — | US | disclosed |
| US-7108846-B1 | Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection | UNIVERSITE CATHOLIQUE DE LOUVAN (BE) | 2006-09-19 | — | — | US | disclosed |
| US-20060159618-A1 | Preparation of compounds useful for the detection of hypoxia | THE UNIVERSITY OF PENNSYLVANIA | 2006-07-20 | — | — | US | disclosed |
| US-6855828-B1 | Detection of hypoxia | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2005-02-15 | — | — | US | disclosed |
| US-20050026974-A1 | Detection of hypoxia | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2005-02-03 | — | — | US | disclosed |
| US-6252087-B1 | COMPLEXING WITH A PROTEIN | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2001-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388585-A1 | PRMT5 INHIBITORS AND USES THEREOF | PRMT1, PRMT5, PRMT6 | LMNA 1373/4885THRB 1508/4885CYP2C19 4791/4885 |
| US-20260118497-A1 | Doppler Velocity Recovery and Dealiasing Algorithm for Multi-PRT Scans in Weather Radars | PRF1, VEGFA, RYR2 | LMNA 1460/4885THRB 1813/4885CYP2C19 1519/4885 |
| US-20050026974-A1 | Detection of hypoxia | HIF1A, HIF1AN, HYOU1 | LMNA 4407/4885THRB 3873/4885CYP2C19 3405/4885 |
| US-20060159618-A1 | Preparation of compounds useful for the detection of hypoxia | HIF1AN, HIF1A, HYOU1 | LMNA 1709/4885THRB 2268/4885CYP2C19 2131/4885 |
| US-12448388-B2 | PRMT5 inhibitors and uses thereof | PRMT5, PRMT1, PRMT9 | LMNA 2517/4885THRB 3384/4885CYP2C19 4284/4885 |
| US-20260062716-A1 | LIPID NANOPARTICLE (LNP) COMPOSITION OR FORMULATION FOR NUCLEIC ACID THERAPEUTICS | CETP, PLTP, LDLR | LMNA 123/4885THRB 2528/4885CYP2C19 4186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.